B Peters

766 total citations
17 papers, 511 citations indexed

About

B Peters is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, B Peters has authored 17 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in B Peters's work include HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV-related health complications and treatments (5 papers). B Peters is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV-related health complications and treatments (5 papers). B Peters collaborates with scholars based in United Kingdom, United States and Netherlands. B Peters's co-authors include Ian Phillips, Margaret Webster, Mary Rahman, B. Cookson, W. C. Noble, A J Pinching, Ranjababu Kulasegaram, Michael Aboud, Ali Elgalib and Gunhild L. Vejlsgaard and has published in prestigious journals such as Journal of Clinical Microbiology, BMJ and The Journal of Urology.

In The Last Decade

B Peters

16 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Peters United Kingdom 10 256 160 98 77 77 17 511
Peter Mariuz United States 9 246 1.0× 242 1.5× 38 0.4× 76 1.0× 140 1.8× 14 603
Sandrine Hénard France 11 215 0.8× 221 1.4× 51 0.5× 43 0.6× 95 1.2× 27 526
Manuel Fernández Guerrero Spain 13 257 1.0× 192 1.2× 35 0.4× 41 0.5× 78 1.0× 46 588
José M. Miró Spain 13 504 2.0× 457 2.9× 101 1.0× 65 0.8× 42 0.5× 18 733
José Ramón Paño Spain 10 201 0.8× 93 0.6× 28 0.3× 40 0.5× 44 0.6× 20 403
Emmanuelle Boffi El Amari Switzerland 11 164 0.6× 296 1.9× 74 0.8× 53 0.7× 17 0.2× 22 674
William E. Maher United States 8 418 1.6× 93 0.6× 34 0.3× 61 0.8× 74 1.0× 14 559
A Terragna Italy 15 177 0.7× 318 2.0× 47 0.5× 32 0.4× 31 0.4× 46 676
Shulin Qin United States 13 154 0.6× 237 1.5× 20 0.2× 183 2.4× 38 0.5× 37 697
Michael J. Borucki United States 12 428 1.7× 274 1.7× 31 0.3× 57 0.7× 182 2.4× 22 632

Countries citing papers authored by B Peters

Since Specialization
Citations

This map shows the geographic impact of B Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Peters more than expected).

Fields of papers citing papers by B Peters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Peters. The network helps show where B Peters may publish in the future.

Co-authorship network of co-authors of B Peters

This figure shows the co-authorship network connecting the top 25 collaborators of B Peters. A scholar is included among the top collaborators of B Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Peters. B Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Peters, B, et al.. (2024). Strengthening tobacco control research: key factors impacting policy outcomes and health equity. Frontiers in Public Health. 12. 1501326–1501326.
2.
Peters, B, et al.. (2020). [A boy with white sponge naevus of the buccal mucosa].. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 164. 1 indexed citations
3.
Reek, J.M.P.A. van den, J.M.M. Groenewoud, Marisol E. Otero, et al.. (2019). Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry. Journal of the European Academy of Dermatology and Venereology. 33(10). 1913–1920. 33 indexed citations
4.
Pitkänen, Mikko R. A., Ranjababu Kulasegaram, Sarah J. Casey, et al.. (2018). HIV: ageing, cognition and neuroimaging at 4‐year follow‐up. HIV Medicine. 19(6). 376–385. 14 indexed citations
5.
Samuel, Miriam, Alan Winston, & B Peters. (2015). Drug treatment for adults with HIV infection. BMJ. 350(apr23 9). h1555–h1555. 1 indexed citations
6.
Peters, B, Frank A. Post, Anthony S. Wierzbicki, et al.. (2012). Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach. HIV Medicine. 14(S1). 1–11. 28 indexed citations
7.
Rockstroh, Jürgen K., Rachel E. Pollard, Giuseppe Pantaleo, et al.. (2012). Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine. Retrovirology. 9(S2). 1 indexed citations
8.
Whittall, Trevor, B Peters, D Rahman, et al.. (2011). Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control. Clinical & Experimental Immunology. 166(2). 208–217. 24 indexed citations
9.
Peters, B, et al.. (2010). Fracture risk in HIV and the need for guidelines: the Probono‐1 Trial. Journal of the International AIDS Society. 13(S4). 2 indexed citations
10.
Gray, Kimberly, et al.. (2008). Participation in two phase II prophylactic HIV vaccine trials in the UK. Vaccine. 26(23). 2919–2924. 8 indexed citations
11.
Aboud, Michael, Ali Elgalib, Ranjababu Kulasegaram, & B Peters. (2007). Insulin resistance and HIV infection: a review. International Journal of Clinical Practice. 61(3). 463–472. 51 indexed citations
12.
Kulasegaram, Ranjababu, Birgitte Giersing, Clive Page, et al.. (2001). In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection. European Journal of Nuclear Medicine and Molecular Imaging. 28(6). 756–761. 28 indexed citations
13.
Patel, R, Neil Bodsworth, P D Woolley, et al.. (1998). Valaciclovir for the Suppression of Recurrent Genital HSV Infection: A Placebo Controlled Study of Once Daily Therapy. The Journal of Urology. 159(4). 1421–1421. 25 indexed citations
14.
Patel, R, Neil Bodsworth, P D Woolley, et al.. (1997). Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.. Sexually Transmitted Infections. 73(2). 105–109. 71 indexed citations
15.
Cowan, Frances M., et al.. (1996). Undergraduate teaching of genitourinary medicine in Britain--what are the issues?. Sexually Transmitted Infections. 72(1). 6–8. 6 indexed citations
16.
Peters, B & A J Pinching. (1989). Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex.. BMJ. 298(6673). 605.3–605. 35 indexed citations
17.
Cookson, B., B Peters, Margaret Webster, et al.. (1989). Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology. 27(7). 1471–1476. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026